These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12373046)

  • 1. Correlation between ST-T-segment changes with markers of hemostasis in patients with acute coronary syndromes.
    Ehlers R; Büttcher E; Eltzschig HK; Kazmaier S; Szabo S; Helber U; Hoffmeister HM
    Cardiology; 2002; 98(1-2):40-5. PubMed ID: 12373046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and their association with clinical outcome, troponin T and C-reactive protein in patients with acute coronary syndromes.
    Postadzhiyan AS; Tzontcheva AV; Kehayov I; Finkov B
    Clin Biochem; 2008 Feb; 41(3):126-33. PubMed ID: 18061588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A study on the reserve capacity of endothelial tissue plasminogen activator in patients with acute coronary syndrome].
    Yan J; Huang Z; Liu R; Li L; Han C; Yang J
    Zhonghua Nei Ke Za Zhi; 1999 Dec; 38(12):817-20. PubMed ID: 11798724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Haemostatic and inflammation markers in acute coronary syndromes and its relationship with adverse cardiovascular events].
    Díaz CJ; Núñez AC; Flores MI; Arcaute HD; Archondo T
    Arch Cardiol Mex; 2006; 76(4):366-75. PubMed ID: 17315612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum lipoprotein(a) level is related to thrombin generation and spontaneous intermittent coronary occlusion in patients with acute myocardial infarction.
    Haider AW; Andreotti F; Thompson GR; Kluft C; Maseri A; Davies GJ
    Circulation; 1996 Nov; 94(9):2072-6. PubMed ID: 8901653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between minor myocardial damage and inflammatory acute-phase reaction in acute coronary syndromes.
    Hoffmeister HM; Ehlers R; Büttcher E; Steinmetz A; Kazmaier S; Helber U; Szabo S; Beyer ME; Seipel L
    J Thromb Thrombolysis; 2003 Feb; 15(1):33-9. PubMed ID: 14574074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial troponin T release is associated with enhanced fibrinolysis in patients with acute coronary syndromes.
    Ehlers R; Büttcher E; Kazmaier S; Beyer ME; Helber U; Szabo S; Wendel HP; Hoffmeister HM
    Thromb Haemost; 2001 Nov; 86(5):1176-80. PubMed ID: 11816703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum amyloid A is a better predictor of clinical outcomes than C-reactive protein in non-ST-segment elevation acute coronary syndromes.
    Kosuge M; Ebina T; Ishikawa T; Hibi K; Tsukahara K; Okuda J; Iwahashi N; Ozaki H; Yano H; Kusama I; Nakati T; Umemura S; Kimura K
    Circ J; 2007 Feb; 71(2):186-90. PubMed ID: 17251664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and incident coronary heart disease: the PRIME Study.
    Luc G; Arveiler D; Evans A; Amouyel P; Ferrieres J; Bard JM; Elkhalil L; Fruchart JC; Ducimetiere P;
    Atherosclerosis; 2003 Sep; 170(1):169-76. PubMed ID: 12957696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment modalities of non-ST-elevation acute coronary syndromes in the real world. Results of the prospective R.OS.A.I.-2 registry.
    Registro Osservazionale Angina Instabile Investigators
    Ital Heart J; 2003 Nov; 4(11):782-90. PubMed ID: 14699708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adiponectinemia, inflammatory process activity, and endothelial dysfunction in patients with type 2 diabetes and acute coronary syndrome with ST elevation in relation to the severity of lesions in the coronary arteries].
    Miłosz D; Czupryniak L; Saryusz-Wolska M; Zasadzińska G; Borkowska A; Cieplucha E; Chizyński K; Loba J
    Pol Arch Med Wewn; 2007 Aug; 117(8):343-9. PubMed ID: 18018381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of myocardial damage prior to hospital admission among patients with acute chest pain or other symptoms raising a suspicion of acute coronary syndrome.
    Svensson L; Isaksson L; Axelsson C; Nordlander R; Herlitz J
    Coron Artery Dis; 2003 May; 14(3):225-31. PubMed ID: 12702926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.
    Thompson SG; Kienast J; Pyke SD; Haverkate F; van de Loo JC
    N Engl J Med; 1995 Mar; 332(10):635-41. PubMed ID: 7845427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Which hemostatic markers add to the predictive value of conventional risk factors for coronary heart disease and ischemic stroke? The Caerphilly Study.
    Smith A; Patterson C; Yarnell J; Rumley A; Ben-Shlomo Y; Lowe G
    Circulation; 2005 Nov; 112(20):3080-7. PubMed ID: 16286603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory biomarkers, death, and recurrent nonfatal coronary events after an acute coronary syndrome in the MIRACL study.
    Zamani P; Schwartz GG; Olsson AG; Rifai N; Bao W; Libby P; Ganz P; Kinlay S;
    J Am Heart Assoc; 2013 Jan; 2(1):e003103. PubMed ID: 23525424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes.
    Baldus S; Heeschen C; Meinertz T; Zeiher AM; Eiserich JP; Münzel T; Simoons ML; Hamm CW;
    Circulation; 2003 Sep; 108(12):1440-5. PubMed ID: 12952835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long term risk stratification of patients with acute coronary syndromes: characteristics of troponin T testing and continuous ST segment monitoring.
    Nørgaard BL; Andersen K; Thygesen K; Ravkilde J; Abrahamsson P; Grip L; Dellborg M
    Heart; 2004 Jul; 90(7):739-44. PubMed ID: 15201240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy].
    Goto S; Handa S; Abe S; Takahashi E; Kawai Y; Watanabe K; Yoshikawa T; Hori S; Ikeda Y
    J Cardiol; 1993; 23(4):335-41. PubMed ID: 8064582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of inflammation in acute coronary syndromes assessed by levels of high-sensitivity C-reactive protein, matrix metalloproteinase-9 and soluble vascular-cell adhesion molecule-1.
    Nomoto K; Oguchi S; Watanabe I; Kushiro T; Kanmatsuse K
    J Cardiol; 2003 Nov; 42(5):201-6. PubMed ID: 14658408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-reactive protein in patients with acute coronary syndrome: correlation with diagnosis, myocardial damage, ejection fraction and angiographic findings.
    Brunetti ND; Troccoli R; Correale M; Pellegrino PL; Di Biase M
    Int J Cardiol; 2006 May; 109(2):248-56. PubMed ID: 16055214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.